Research & Development
LENZ Therapeutics advances VIZZ regulatory expansion with UK submission for presbyopia treatment
20 April 2026 - US pharmaceutical company LENZ Therapeutics Inc (Nasdaq:LENZ) announced on Monday that it has submitted a marketing authorisation application (MAA) to the United Kingdom's Medicin...
Lundbeck presents new real-world data on VYEPTI (eptinezumab) at AAN 2026
20 April 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH:HLUN-A) on Sunday presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 A...
European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe
17 April 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday that the European Commission has approved ENFLONSIA (clesrovimab) f...
Cumberland Pharmaceuticals secures FDA approval for expanded Caldolor indication
...
Philips secures FDA clearance for Spectral CT Verida system
...
Adimab partner GSK receives additional marketing approvals for depemokimab
16 April 2026 - Adimab LLC, a provider of therapeutic antibody discovery and engineering technologies, said on Wednesday that it congratulates biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) fo...